E-ISSN: 1305-3612
    Imaging features of bone metastases in patients with gastrointestinal stromal tumors
    PDF
    Cite
    Share
    Request
    Musculoskeletal Imaging - Original Article
    VOLUME: 18 ISSUE: 4
    P: 391-396
    July 2012

    Imaging features of bone metastases in patients with gastrointestinal stromal tumors

    Diagn Interv Radiol 2012;18(4):391-396
    DOI: 10.4261/1305-3825.DIR.5179-11.1
    Anupma Jati, 1
    Servet Tatlı, 2
    Jeffrey A. Morgan, 1
    Jonathan N. Glickman, 3
    George D. Demetri, 1
    Annick Van den Abbele, 1
    Stuart G. Silverman 4
    1. Department of Radiology and Oncology, Harvard Medical School, Dana Farber Cancer Institute, Boston, Massachusetts, USA
    2. Department of Radiology and Oncology, Harvard Medical School, Dana Farber Cancer Institute, Boston, Massachusetts, USA
    3. Division of Abdominal Imaging and Interventional Radiology, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    4. Department of Radiology and Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA
    5. Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA.
    No information available.
    No information available
    Received Date: 27.09.2011
    Accepted Date: 24.10.2011
    PDF
    Cite
    Share
    Request

    ABSTRACT

    PURPOSE

    To determine the prevalence and imaging features of bone metastases in patients with gastrointestinal stromal tumors (GISTs).

    MATERIALS AND METHODS

    The medical records of 190 patients with pathologically proven GISTs were reviewed, and patients with bone metastases were identified. Computed tomography (CT) scans of the chest, abdomen, and pelvis were examined for features of bone metastases, and findings were correlated with the results of positron-emission tomography (PET) and histopathology.The medical records of 190 patients with pathologically proven GISTs were reviewed, and patients with bone metastases were identified. Computed tomography (CT) scans of the chest, abdomen, and pelvis were examined for features of bone metastases, and findings were correlated with the results of positron-emission tomography (PET) and histopathology.

    RESULTS

    Of 190 GIST patients, six (3.2%) had bone metastases: four patients had multiple bone metastases, and two patients had a solitary metastasis. The maximum diameter of the metastases ranged from 2 to 40 mm, and they most commonly involved the vertebrae, ribs, pelvic bones, and femurs. All lesions were well-marginated and lytic. A soft tissue component was identified in three patients. The bone metastases showed intense fluorine-18 fluorodeoxyglucose (FDG) uptake. After treatment with imatinib mesylate in three patients, the bone metastases developed peripheral sclerosis on CT and became less FDG-avid on PET. All six primary tumors were morphologically high-grade with high mitotic rates and necrosis.

    CONCLUSION

    Bone metastases from GISTs are uncommon; when detected with CT, they are characterized by single or multiple lytic lesions with or without soft tissue involvement. A sclerotic rim may appear around the metastatic lesions in response to treatment. Similar to the disease in other sites, bone metastases show intense FDG uptake, which decreases following treatment.

    Keywords: gastrointestinal stromal tumors, metastases, bone, positron-emission tomography and computed tomography

    References

    2024 ©️ Galenos Publishing House